Pharma Innovations of 2022 – A World Pharma Today Round Table.

This World Pharma Today exclusive with opinion makers is all about innovations that are in store for 2022 in the areas that have been in the headlines of late. The year that has gone by has had a phenomenal impact on the way we perceive things around us.

Oxford Join Consortium For Advance Quantum Drug Discovery.

SEEQC, which is a digital quantum computing company, and Oxford University have partnered to ensure accelerated use of computing based on the quantum method in the research particularly focused on pharmaceuticals.

COVID-19 Vaccines May Need Updation For Omicron- WHO Body.

The technical body of the World Health Organization has confirmed that the COVID-19 vaccines, which the world is using currently, may have to be reworked to ensure their effectiveness against not only Omicron but future variants as well that may arise from...

Pfizer Shares In Vitro Efficacy of Novel COVID-19 Oral Treatment Against Omicron Variant.

Pfizer shared results from multiple studies demonstrating that the in vitro efficacy of nirmatrelvir, the active main protease inhibitor of PAXLOVID is maintained against the SARS-CoV-2 variant Omicron.

More Than 50% of Europe To Be Under The Clutches of Omicron.

According to the forecast shared by WHO top officials more than half of Europe will suffer from the highly contagious variant of COVID-19, Omicron in the next couple of months. As per one of the top line directors at WHO, there is a sweep of the west to east tidal...

AstraZeneca Sells Half-Million COVID-19 Antibody Doses To US.

After topping off supplies to Pfizer and GlaxoSmithkline, of the COVID-19 vaccine, US has sought AstraZeneca's help of its antibody combo. Notably, the government has already bought another 500,000 doses of antibody cocktail Evusheld plus cilgavimab.

Cystic Fibrosis Treatment Approved By European Commission .

When it comes to cystic fibrosis, which is a debilitating and progressive condition found in around 11000 people in the UK, no cure has been attained. The EC, as it has come to notice, has granted a label extension approval for Kaftrio in a fusio..